| Abstrakt: |
Intracytoplasmic sperm injection (ICSI) is an assisted reproductive technology for treatment of severe male infertility introduced into clinical practice in 1992. This review provides a brief history of the development of ICSI by acknowledging major developments in the field. The review addresses key developments in pre-clinical and early studies, how ICSI compares with in vitro fertilisation, long-term consequences, how the mechanistic approach to ICSI has changed in both manual and semi-automated approaches, and how sperm selection procedures are integrated into ICSI. From the beginnings using animal models in the 1960–1970s, the development of ICSI is a remarkable and transformative success story. Indeed, its broad use (70% of cycles globally) exceeds the need required for treating infertile males, and this remains a controversial issue. There remain questions around the long-term health impacts of ICSI. Furthermore, advances in automation of the ICSI procedure are occurring. An estimated 6 million children have been born from the ICSI procedure. With further automation of sperm selection technologies, coupled with automation of the injection procedure, it is likely that the proportion of children born from ICSI will further increase. Intracytoplasmic sperm injection, better known by its acronym 'ICSI', is a technique that enables the injection of a single sperm into an egg. Since first practiced in 1992 with human sperm and eggs, it has revolutionised the treatment of male infertility, and an estimated 6 million children have since been born. However, it is not without controversy, especially concerning the long-term health of children conceived through ICSI, as well as the recent push towards automation of sperm selection and injection. Image by M. Inge. This article belongs to the Collection Dedication to Jim Cummins. [ABSTRACT FROM AUTHOR] |
